Upgrade to SI Premium - Free Trial

RBC Capital Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Sector Perform, After FDA CRL

August 19, 2020 11:12 AM
RBC Capital analyst Kennen MacKay downgraded BioMarin Pharmaceutical Inc. (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades

Next Articles